A detailed history of Horst & Graben Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Horst & Graben Wealth Management LLC holds 404 shares of LLY stock, worth $366,310. This represents 0.07% of its overall portfolio holdings.

Number of Shares
404
Previous 404 -0.0%
Holding current value
$366,310
Previous $235,000 33.62%
% of portfolio
0.07%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$525.19 - $619.13 $17,331 - $20,431
-33 Reduced 7.55%
404 $235,000
Q3 2023

Oct 24, 2023

SELL
$434.7 - $599.3 $6,085 - $8,390
-14 Reduced 3.1%
437 $234,000
Q2 2023

Jul 25, 2023

BUY
$350.74 - $468.98 $158,183 - $211,509
451 New
451 $211,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Horst & Graben Wealth Management LLC Portfolio

Follow Horst & Graben Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horst & Graben Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horst & Graben Wealth Management LLC with notifications on news.